Iterum Therapeutics Surges 159.55% in Pre-Market Trading

Iterum Therapeutics stock is experiencing a dramatic pre-market surge of 159.55%, capturing investor attention in early trading. The biotech company's shares have been highly volatile in recent months, with the stock down significantly year-to-date despite occasional sharp rallies. Trading volume has remained substantial, reflecting active investor interest in the volatile security. The company's market cap currently stands at $36.04 million, with shares trading in penny stock territory. Read more about this...